These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12819066)

  • 1. Salmonella enterica serovar typhimurium expressing a chromosomally integrated copy of the Bacillus anthracis protective antigen gene protects mice against an anthrax spore challenge.
    Garmory HS; Titball RW; Griffin KF; Hahn U; Böhm R; Beyer W
    Infect Immun; 2003 Jul; 71(7):3831-6. PubMed ID: 12819066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis.
    Stokes MG; Titball RW; Neeson BN; Galen JE; Walker NJ; Stagg AJ; Jenner DC; Thwaite JE; Nataro JP; Baillie LW; Atkins HS
    Infect Immun; 2007 Apr; 75(4):1827-34. PubMed ID: 17145938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthrax protective antigen delivered by Salmonella enterica serovar Typhi Ty21a protects mice from a lethal anthrax spore challenge.
    Osorio M; Wu Y; Singh S; Merkel TJ; Bhattacharyya S; Blake MS; Kopecko DJ
    Infect Immun; 2009 Apr; 77(4):1475-82. PubMed ID: 19179420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacillus anthracis protective antigen, expressed in Salmonella typhimurium SL 3261, affords protection against anthrax spore challenge.
    Coulson NM; Fulop M; Titball RW
    Vaccine; 1994 Nov; 12(15):1395-401. PubMed ID: 7887017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptation of the endogenous Salmonella enterica serovar Typhi clyA-encoded hemolysin for antigen export enhances the immunogenicity of anthrax protective antigen domain 4 expressed by the attenuated live-vector vaccine strain CVD 908-htrA.
    Galen JE; Zhao L; Chinchilla M; Wang JY; Pasetti MF; Green J; Levine MM
    Infect Immun; 2004 Dec; 72(12):7096-106. PubMed ID: 15557633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.
    Welkos S; Little S; Friedlander A; Fritz D; Fellows P
    Microbiology (Reading); 2001 Jun; 147(Pt 6):1677-1685. PubMed ID: 11390699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes.
    Chitlaru T; Israeli M; Rotem S; Elia U; Bar-Haim E; Ehrlich S; Cohen O; Shafferman A
    Vaccine; 2017 Oct; 35(44):6030-6040. PubMed ID: 28342664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategy.
    Baillie LW; Rodriguez AL; Moore S; Atkins HS; Feng C; Nataro JP; Pasetti MF
    Vaccine; 2008 Nov; 26(48):6083-91. PubMed ID: 18805452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a novel chimeric PA-LF antigen of Bacillus anthracis, its immunological characterization and evaluation as a future vaccine candidate in mouse model.
    Varshney A; Kumar M; Nagar DP; Pal V; Goel AK
    Biologicals; 2019 Sep; 61():38-43. PubMed ID: 31416791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with a Recombinant, Pseudomonas fluorescens-Expressed, Mutant Form of Bacillus anthracis-Derived Protective Antigen Protects Rabbits from Anthrax Infection.
    Reed MD; Wilder JA; Mega WM; Hutt JA; Kuehl PJ; Valderas MW; Chew LL; Liang BC; Squires CH
    PLoS One; 2015; 10(7):e0130952. PubMed ID: 26207820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
    Bielinska AU; Janczak KW; Landers JJ; Makidon P; Sower LE; Peterson JW; Baker JR
    Infect Immun; 2007 Aug; 75(8):4020-9. PubMed ID: 17502384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced vaccine antigen delivery by Salmonella using antibiotic-free operator-repressor titration-based plasmid stabilisation compared to chromosomal integration.
    Leckenby MW; Spear AM; Neeson BN; Williamson ED; Cranenburgh RM; Atkins HS
    Microb Pathog; 2009 Apr; 46(4):201-6. PubMed ID: 19490834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of antibody responses to Bacillus anthracis protective antigen domain IV by use of calreticulin as a chimeric molecular adjuvant.
    Park YS; Lee JH; Hung CF; Wu TC; Kim TW
    Infect Immun; 2008 May; 76(5):1952-9. PubMed ID: 18285494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization against anthrax using Bacillus subtilis spores expressing the anthrax protective antigen.
    Duc le H; Hong HA; Atkins HS; Flick-Smith HC; Durrani Z; Rijpkema S; Titball RW; Cutting SM
    Vaccine; 2007 Jan; 25(2):346-55. PubMed ID: 17007969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen.
    Peachman KK; Rao M; Alving CR; Burge R; Leppla SH; Rao VB; Matyas GR
    Infect Immun; 2006 Jan; 74(1):794-7. PubMed ID: 16369043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A plant based protective antigen [PA(dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax.
    Gorantala J; Grover S; Goel D; Rahi A; Jayadev Magani SK; Chandra S; Bhatnagar R
    Vaccine; 2011 Jun; 29(27):4521-33. PubMed ID: 21504775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Killed but metabolically active Bacillus anthracis vaccines induce broad and protective immunity against anthrax.
    Skoble J; Beaber JW; Gao Y; Lovchik JA; Sower LE; Liu W; Luckett W; Peterson JW; Calendar R; Portnoy DA; Lyons CR; Dubensky TW
    Infect Immun; 2009 Apr; 77(4):1649-63. PubMed ID: 19168734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components.
    Mendelson I; Gat O; Aloni-Grinstein R; Altboum Z; Inbar I; Kronman C; Bar-Haim E; Cohen S; Velan B; Shafferman A
    Vaccine; 2005 Dec; 23(48-49):5688-97. PubMed ID: 16039760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of mice against challenge with Bacillus anthracis STI spores after DNA vaccination.
    Hahn UK; Alex M; Czerny CP; Böhm R; Beyer W
    Int J Med Microbiol; 2004 Jul; 294(1):35-44. PubMed ID: 15293452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant Sindbis virus vectors designed to express protective antigen of Bacillus anthracis protect animals from anthrax and display synergy with ciprofloxacin.
    Thomas JM; Moen ST; Gnade BT; Vargas-Inchaustegui DA; Foltz SM; Suarez G; Heidner HW; König R; Chopra AK; Peterson JW
    Clin Vaccine Immunol; 2009 Nov; 16(11):1696-9. PubMed ID: 19759250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.